Chapters - Switzerland

The Swiss ISoP Chapter was founded in April 2009 and officially announced in October 2009 at the ISoP Annual Meeting in Reims (France).
ISoP Chapters Swiss / Austrian

Swiss Chapter – Informal Discussion

27th August 2022 - 12:00 CET

All ISoP current/ future members residing within Switzerland and Austria are invited for an informal discussion on Aug 27, 2022, at 12.00 CET regarding future chapter events. We will discuss committee appointments, chapter meetings, webinars, etc. All ideas or thoughts to uplift the chapter will be highly appreciated. The chapter meeting will be a hybrid event. We look forward to meeting many of you.
Dr. Joan D’souza, ISoP Chair for Switzerland & Austria


The chapter has an educational role with the objective to increase knowledge and to ensure trainings in the field of Pharmacovigilance. The Chapter scientific meeting, generally in spring, attracts people working in many different areas of pharmacovigilance – an ideal networking platform. The chapter fosters relations between Academia, Clinicians, regulatory bodies and pharmaceutical companies as well as with other pharmacovigilance related organisations. All ISoP members are cordially welcome. Membership of the Swiss ISoP Chapter is open to all ISoP members, free of costs (besides the Individual membership fee for ISoP).
Members benefit from reductions of participant’s fees for symposia and other scientific events organized by the Swiss Chapter.


The 18th ISoP Annual Meeting took place on 11th-14th November 2018 at the International Conference Centre Geneva (CICG), located near the United Nations, 10 minutes from the airport and the city centre on a convenient bus route.
The local organiser was Dr Victoria Rollason from the Hôpitaux Universitaires de Genève, and President coordinator of the ISoP Swiss Chapter.

Advisory Board

Appointed 2018

Chapter President coordinator:
Dr. Victoria Rollason
University Hospital Geneva

Vice-President / Deputy:
Prof. Dr. Stefan Russmann

Chapter Treasurer:
Dr. Mario Bertazzoli
Director, Head of Corporate Drug Safety, Helsinn Group, Lugano

David Niedrig
University Children’s Hospital Zurich and



ISoP Swiss Chapter
Meetings Archive